750332C

14:0 Cardiolipin (sodium salt)

1′,3′-bis[1,2-dimyristoyl-sn-glycero-3-phospho]-glycerol (sodium salt), chloroform

• 別名: 1,1′,2,2′-tetratetradecanoyl cardiolipin (sodium salt); CL(1′-[14:0/14:0],3′-[14:0/14:0])
• 実験式（ヒル表記法）: C₆₅H₁₂₄Na₂O₁₇P₂
• CAS番号: 63988-21-6
• 分子量: 1285.60
• MDL番号: MFCD00201315
• UNSPSCコード: 51191904
• NACRES: NA.25

特性

• アッセイ: >99% (TLC)
• フォーム: solution
• 包装: pkg of 1 × 2.5 mL (750332C-25mg); pkg of 2 × 4 mL (750332C-200mg)
• メーカー／製品名: Avanti Research^™ - A Croda Brand 750332C
• 濃度: 10 mg/mL (750332C-25mg); 25 mg/mL (750332C-200mg)
• 脂質タイプ: phospholipids; cardiolipins
• 輸送温度: dry ice
• 保管温度: −20°C

詳細

詳細

Cardiolipin, the mitochondrial-specific phospholipid, helps maintain mitochondrial function, membrane potential and structural support for the inner mitochondrial membrane and the proteins in it. Concentration and composition changes of cardiolipin have been implicated in pathological conditions including ischemia, hypothyroidism, aging, heart failure and cardioskeletal myopathy (Barth syndrome). Cardiolipin has also been shown as a signaling molecule in apoptosis.

アプリケーション

14:0 Cardiolipin (sodium salt) has been used for the mass spectrometry (MS) analysis to determine the structure of lipid A.

包装

5 mL Clear Glass Sealed Ampule (750332C-200mg)

5 mL Clear Glass Sealed Ampule (750332C-25mg)

法的情報

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全性情報

• ピクトグラム: GHS06,GHS08
• シグナルワード: Danger
• 危険有害性情報: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• 注意書き: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• 危険有害性の分類: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• ターゲットの組織: Central nervous system, Liver,Kidney
• WGK: WGK 3